ZHEN-AO GROUP Unveils TRIAL RESULTS: 5'-Nucleotide Reduces DNA Methylation Age by 3.08 Years

发布日期:2025-08-27 文章来源:美联社 浏览量:0

PARIS--(BUSINESS WIRE)--Aug 27, 2025--

On August 24, 2025, the 23rd International Congress of Nutrition (ICN) convened in Paris, France, under the theme “Sustainable Food for Global Health.” As the premier platform in nutritional science, the event brought together experts from 120 countries.

At the conference, researcher Mei-Hong Xu from Peking University presented groundbreaking findings from a randomized double-blind human trial (RCT) on nucleotide-based anti-aging. The study demonstrated that 5'-nucleotide supplementation over 19 weeks reduced DNA methylation age—the gold standard for epigenetic aging—by an average of 3.08 years in 60-70-year-old participants, alongside improvements in insulin resistance and visceral fat. The 5'-nucleotides, derived from yeast hydrolysis of eukaryotic cells, were validated in the study published in the prestigious journal Advanced Science.

上一篇 : FinanzNachrichten.de:ZHEN-AO GROUP CO., LTD.: ZHEN-AO GROUP Unveils TRIAL RESULTS: 5'-Nucleotide Reduces DNA Methylation Age by 3.08 Years

下一篇 :人民日报海外版:核苷酸抗衰老成果发布

相关推荐